Discover 1,812 paid clinical trials in Tennessee. Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.
Whether you're a healthy volunteer interested in paid studies or someone looking for trials focused on specific conditions, Tennessee offers a wide variety of clinical research options. Leading facilities in Nashville, Memphis, and Knoxville are currently seeking participants, providing opportunities for individuals to access innovative treatments and specialized healthcare.
Filter
1
Filter results
Results: 1,812
Active & Responsive
Responding With Evidence and Access for Childhood Headaches
Location: Philadelphia PA, Wilmington DE, Amherst NY,
Sponsor: Children's Hospital Medical Center, Cincinnati
Sex: All
Age: 10 - 17
Code: NCT05889624
Recruiting
Active & Responsive
The Artisse™ Intrasaccular Device is Indicated for the Treatment of Wide-neck Bifurcating Intracranial Aneurysms (IAs).
for
Intracranial Aneurysm
Location: Boston MA, New Haven CT, Stony Brook NY, New York NY,
Sponsor: Medtronic Neurovascular Clinical Affairs
Sex: All
Age: 18 - 70+
Code: NCT02998229
Recruiting
Active & Responsive
A Novel, Regulated Gene Therapy (NGN-401) Study for Females With Rett Syndrome
for
Rett Syndrome
Location: Boston MA, New York NY, Baltimore MD, Chapel Hill NC,
Sponsor: Neurogene Inc.
Sex: Female
Age: 3+
Code: NCT05898620
Phase3, Recruiting
Active & Responsive
A Study of CLN-978, a Subcutaneously Administered CD19-directed T Cell Engager, in Subjects With Sjogren's Disease
for
Sjögren, Sjogren Disease, Sjogren's Syndrome
Location: Orlando FL, Memphis TN, Webster TX, Plano TX,
Sponsor: Cullinan Therapeutics Inc.
Sex: All
Age: 18+
Code: NCT07041099
Phase1, Recruiting
Active & Responsive
A Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) as Monotherapy and in Combination With Pembrolizumab (MK-3475) in Participants With Triple-Negative Breast Cancer (MK-2870-011/TroFuse-011)
for
Triple Negative Breast Neoplasms
Location: Quebec, Chicoutimi, Mineola NY, New York NY,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 18+
Code: NCT06841354
Phase3, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Active & Responsive
Measuring if Immunotherapy Plus Chemotherapy is Better Than Chemotherapy Alone for Patients With Aggressive Poorly Differentiated Sarcomas
for
Metastatic Dedifferentiated Liposarcoma,
Location: Boston MA, Waterford CT, Guilford CT, New Haven CT,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT06422806
Phase3, Recruiting
Active & Responsive
A Phase 1/2 Study of BHV-1510 (Previously PBI-410) in Advanced Solid Tumors
for
Solid Tumor
Location: New York NY, Philadelphia PA, Washington D.C. DC,
Sponsor: Biohaven Therapeutics Ltd.
Sex: All
Age: 18+
Code: NCT06384807
Phase1, Phase2, Recruiting
Active & Responsive
A Randomized Comparison of Personalized Therapy Mgmt Based On Coronary Atherosclerotic Plaque Vs. Usual Care for Symptomatic Patients With Suspicion of CAD
for
Coronary Artery Disease
Location: Albany NY, Flemington NJ, Bowie MD, Richmond VA,
Sponsor: Cleerly, Inc.
Sex: All
Age: 18+
Code: NCT06713239
Recruiting
Active & Responsive
A Randomized Comparison of Stage-Based Care Versus Risk Factor-Based Care for Prevention of Cardiovascular Events
for
Diabetes Mellitus, Type 2, PreDiabetes, Metabolic Syndrome
Location: Boston MA, Lake Success NY, Mount Kisco NY,
Sponsor: Cleerly, Inc.
Sex: All
Age: 55+
Code: NCT06112418
Recruiting
Active & Responsive
A Study of PARG Inhibitor IDE161 in Participants With Advanced Solid Tumors
for
Advanced or Metastatic Solid Tumors, Breast Cancer,
Location: Boston MA, New Haven CT, New York NY, Philadelphia PA,